95 results
SC TO-T
EX-99
BMY
Bristol-Myers Squibb Co.
25 Jan 24
Third party tender offer statement
8:13am
“clean team folders” in an electronic data site maintained by or on behalf of the Provider, which Confidential Information shall be made available
DFAN14A
KRTX
Karuna Therapeutics Inc
22 Dec 23
Additional proxy materials by non-management
4:36pm
for new option that provides strong efficacy, clean safety and ability to add onto existing medicines Potential first-in-disease treatment for ADP
8-K
EX-10.1
1t4 js294mq0
6 Nov 20
Entry into a Material Definitive Agreement
8:00am
8-K
EX-10.2
000 r0eu5tu2k
30 Jan 19
Entry into a Material Definitive Agreement
4:45pm
8-K
EX-10.1
le1jqsqffvq
30 Jan 19
Entry into a Material Definitive Agreement
4:45pm
425
EX-10.1
6gq9fi1
30 Jan 19
Business combination disclosure
4:43pm
425
EX-10.2
0301zvovqdqhjr
30 Jan 19
Business combination disclosure
4:43pm
8-K
EX-10.1
1gzd1koj lrmrdc
22 Jan 19
Entry into a Material Definitive Agreement
4:37pm
425
EX-10.1
byj6vbv7
22 Jan 19
Business combination disclosure
4:35pm
8-K
EX-2.1
u3tg57q2cqt4o3h905
4 Jan 19
Entry into a Material Definitive Agreement
8:52am
425
EX-2.1
wxflwr7qpmezj
4 Jan 19
Business combination disclosure
8:50am